Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Birnbaum

Showing results (31-40 of 344) with videos related to

Pageof 35
Sort By:
Cell Cycle (Georgetown, Tex.)|March 1, 2012
The emerging role of the TGFβ tumor suppressor pathway in pancreatic cancerDavid J Birnbaum, Emilie Mamessier, Daniel Birnbaum
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 15, 2005
An evolutionary history of the FGF superfamilyCornel Popovici, Régine Roubin, François Coulier, et al.
Cancer Letters|September 15, 2014
EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancerFrançois Bertucci, Pascal Finetti, Patrice Viens, et al.
Oncoimmunology|May 4, 2016
The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancersFrançois Bertucci, Pascal Finetti, Daniel Birnbaum, et al.
Medecine Sciences : M/S|June 15, 2017
[Circulating tumor cells: a real time dive into malignant plasticity]Alexia Lopresti, Claire Acquaviva, Daniel Birnbaum, et al.
Neuroscience Letters|August 6, 2002
Caenorhabditis elegans receptors related to mammalian vascular endothelial growth factor receptors are expressed in neural cellsCornel Popovici, Daniel Isnardon, Daniel Birnbaum, et al.
Cell Cycle (Georgetown, Tex.)|October 28, 2010
The CINSARC signature: prognostic and predictive of response to chemotherapy?François Bertucci, Pascal Finetti, Renaud Sabatier, et al.
Medecine Sciences : M/S|September 2, 2011
[Genome: does a paucity of initiation events lead to fragility?]Anne Letessier, Daniel Birnbaum, Michelle Debatisse, et al.
Medecine Sciences : M/S|July 8, 2008
[Prognostic classification of breast cancer and gene expression profiling]François Bertucci, Pascal Finetti, Nathalie Cervera, et al.
NPJ Breast Cancer|March 21, 2020
The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtypeFrançois Bertucci, Pascal Finetti, Anthony Goncalves, et al.
Pageof 35

Showing results (31-40 of 344) with videos related to

Sort By:
Pageof 35
Cell Cycle (Georgetown, Tex.)|March 1, 2012
The emerging role of the TGFβ tumor suppressor pathway in pancreatic cancerDavid J Birnbaum, Emilie Mamessier, Daniel Birnbaum
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 15, 2005
An evolutionary history of the FGF superfamilyCornel Popovici, Régine Roubin, François Coulier, et al.
Cancer Letters|September 15, 2014
EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancerFrançois Bertucci, Pascal Finetti, Patrice Viens, et al.
Oncoimmunology|May 4, 2016
The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancersFrançois Bertucci, Pascal Finetti, Daniel Birnbaum, et al.
Medecine Sciences : M/S|June 15, 2017
[Circulating tumor cells: a real time dive into malignant plasticity]Alexia Lopresti, Claire Acquaviva, Daniel Birnbaum, et al.
Neuroscience Letters|August 6, 2002
Caenorhabditis elegans receptors related to mammalian vascular endothelial growth factor receptors are expressed in neural cellsCornel Popovici, Daniel Isnardon, Daniel Birnbaum, et al.
Cell Cycle (Georgetown, Tex.)|October 28, 2010
The CINSARC signature: prognostic and predictive of response to chemotherapy?François Bertucci, Pascal Finetti, Renaud Sabatier, et al.
Medecine Sciences : M/S|September 2, 2011
[Genome: does a paucity of initiation events lead to fragility?]Anne Letessier, Daniel Birnbaum, Michelle Debatisse, et al.
Medecine Sciences : M/S|July 8, 2008
[Prognostic classification of breast cancer and gene expression profiling]François Bertucci, Pascal Finetti, Nathalie Cervera, et al.
NPJ Breast Cancer|March 21, 2020
The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtypeFrançois Bertucci, Pascal Finetti, Anthony Goncalves, et al.
Pageof 35